Es gab 50 kürzliche Insider-Transaktionen für Ensysce Biosciences, Inc. (ENSC), darunter 35 Käufe und 3 Verkäufe. Die gesamten Insider-Käufe beliefen sich auf $23.54M und die gesamten Insider-Verkäufe auf $3.12M.
Bedeutende Insider mit kürzlicher Aktivität umfassen Gower Bob G, Martin Steven Robert, Chang William H. Insider-Transaktionen können Einblicke geben, wie die Unternehmensführung die Bewertung und Zukunftsaussichten der Aktie einschätzt.
Insider-Transaktionen — ENSC
| Datum |
Name |
Funktion |
Transaktionsart |
Aktien |
Ø Preis |
Wert |
Gehaltene Aktien |
| 2023-03-02 |
Gower Bob G |
Director |
Informierter Kauf |
90,287 |
$0.49 |
$44.09K |
1,222,682 |
| 2023-03-01 |
Gower Bob G |
Director |
Informierter Kauf |
270,000 |
$0.48 |
$128.98K |
1,132,395 |
| 2023-02-28 |
Gower Bob G |
Director |
Informierter Kauf |
109,300 |
$0.49 |
$53.37K |
862,395 |
| 2022-12-09 |
Gower Bob G |
Director |
RSU-Zuteilung |
714,286 |
$1.40 |
$1M |
716,365 |
| 2022-06-23 |
Gower Bob G |
10 Percent Owner |
RSU-Zuteilung |
15,000 |
$0.43 |
$6.38K |
41,585 |
| 2022-06-23 |
Martin Steven Robert |
Director |
RSU-Zuteilung |
15,000 |
- |
- |
100,850 |
| 2022-06-23 |
Chang William H |
Director |
RSU-Zuteilung |
15,000 |
- |
- |
35,000 |
| 2022-06-23 |
Rauch Lee M. |
Director |
RSU-Zuteilung |
15,000 |
- |
- |
35,000 |
| 2022-06-23 |
Benton Andrew |
Director |
RSU-Zuteilung |
15,000 |
- |
- |
100,850 |
| 2022-06-23 |
Levin Adam |
Director |
RSU-Zuteilung |
15,000 |
- |
- |
35,000 |
| 2022-06-23 |
Rosebraugh Curtis |
Director |
RSU-Zuteilung |
20,000 |
- |
- |
35,000 |
| 2022-05-25 |
Kirkpatrick Lynn |
Chief Executive Officer |
Informierter Kauf |
27,000 |
$0.53 |
$14.22K |
381,851 |
| 2022-04-18 |
Osman Nilab |
Chief Medical Officer |
Veräußerung |
200,000 |
$1.07 |
$214K |
- |
| 2022-02-17 |
Kirkpatrick Lynn |
Chief Executive Officer |
RSU-Zuteilung |
200,000 |
$1.40 |
$280K |
200,000 |
| 2022-02-17 |
Humphrey David Carl |
Chief Financial Officer |
RSU-Zuteilung |
80,000 |
$1.40 |
$112K |
80,000 |
| 2022-02-17 |
Birkett Kevin Geoffrey |
Chief Commercial Officer |
RSU-Zuteilung |
50,000 |
$1.40 |
$70K |
50,000 |
| 2022-02-08 |
Rauch Lee M. |
Director |
Veräußerung |
20,000 |
$1.70 |
$34K |
- |
| 2022-02-04 |
Gower Bob G |
10 Percent Owner |
RSU-Zuteilung |
20,000 |
$3.13 |
$62.6K |
20,000 |
| 2022-02-04 |
Martin Steven Robert |
Director |
RSU-Zuteilung |
20,000 |
$3.13 |
$62.6K |
20,000 |
| 2022-02-04 |
Chang William H |
10 Percent Owner |
RSU-Zuteilung |
20,000 |
$3.13 |
$62.6K |
20,000 |
| 2022-02-04 |
Humphrey David Carl |
Chief Financial Officer |
RSU-Zuteilung |
275,000 |
$3.13 |
$860.75K |
275,000 |
| 2022-02-04 |
Benton Andrew |
Director |
RSU-Zuteilung |
20,000 |
$3.13 |
$62.6K |
20,000 |
| 2022-02-04 |
Levin Adam |
Director |
RSU-Zuteilung |
20,000 |
$3.13 |
$62.6K |
20,000 |
| 2022-02-04 |
Rosebraugh Curtis |
Director |
RSU-Zuteilung |
20,000 |
$3.13 |
$62.6K |
20,000 |
| 2022-02-04 |
Pestano Linda |
Chief Development Officer |
RSU-Zuteilung |
200,000 |
$2.48 |
$496K |
200,000 |
| 2021-10-15 |
Pestano Linda |
Officer |
Unbekannt |
- |
- |
- |
- |
| 2021-06-30 |
Weil A Lorne |
10 Percent Owner |
Aktienrückgabe |
250,000 |
$11.50 |
$2.88M |
137,895 |
| 2021-06-30 |
Silvers Daniel B. |
10 Percent Owner |
RSU-Zuteilung |
1,637,390 |
$11.50 |
$18.83M |
1,637,390 |
| 2021-06-30 |
Peng George |
Officer |
RSU-Zuteilung |
15,000 |
$11.50 |
$172.5K |
15,000 |
| 2021-06-30 |
Carrera Eric |
Officer |
RSU-Zuteilung |
30,000 |
$11.50 |
$345K |
30,000 |
| 2021-06-30 |
Gower Bob G |
Director |
Unbekannt |
- |
- |
- |
- |
| 2021-06-30 |
Gower Bob G |
10 Percent Owner |
RSU-Zuteilung |
6,585 |
$2.59 |
$17.06K |
6,585 |
| 2021-06-30 |
Schmidt William K |
Officer |
Unbekannt |
- |
- |
- |
- |
| 2021-06-30 |
Schmidt William K |
Chief Medical Officer |
RSU-Zuteilung |
69,142 |
$3.22 |
$222.64K |
69,142 |
| 2021-06-30 |
Martin Steven Robert |
Director |
Unbekannt |
- |
- |
- |
- |
| 2021-06-30 |
Martin Steven Robert |
Director |
RSU-Zuteilung |
65,850 |
$3.35 |
$220.6K |
65,850 |
| 2021-06-30 |
Kirkpatrick Lynn |
Chief Executive Officer |
Unbekannt |
- |
- |
- |
- |
| 2021-06-30 |
Kirkpatrick Lynn |
Chief Executive Officer |
RSU-Zuteilung |
6,585 |
$2.59 |
$17.06K |
6,585 |
| 2021-06-30 |
Chang William H |
10 Percent Owner |
Unbekannt |
- |
- |
- |
- |
| 2021-06-30 |
Chang William H |
10 Percent Owner |
RSU-Zuteilung |
353,451 |
- |
- |
353,451 |
| 2021-06-30 |
Humphrey David Carl |
Officer |
Unbekannt |
- |
- |
- |
- |
| 2021-06-30 |
Humphrey David Carl |
Chief Financial Officer |
RSU-Zuteilung |
50,000 |
- |
- |
50,000 |
| 2021-06-30 |
Birkett Kevin Geoffrey |
Officer |
Unbekannt |
- |
- |
- |
- |
| 2021-06-30 |
Birkett Kevin Geoffrey |
Chief Commercial Officer |
RSU-Zuteilung |
19,755 |
$2.59 |
$51.17K |
19,755 |
| 2021-06-30 |
Benton Andrew |
Director |
Unbekannt |
- |
- |
- |
- |
| 2021-06-30 |
Benton Andrew |
Director |
RSU-Zuteilung |
65,850 |
$3.35 |
$220.6K |
65,850 |
| 2021-06-30 |
Levin Adam |
Director |
Unbekannt |
- |
- |
- |
- |
| 2021-06-30 |
Millard Jeffrey |
Officer |
Unbekannt |
- |
- |
- |
- |
| 2021-06-30 |
Wright Richard Chester |
Officer |
Unbekannt |
- |
- |
- |
- |
| 2021-06-30 |
Wright Richard Chester |
Chief Business Officer |
RSU-Zuteilung |
19,755 |
- |
- |
19,755 |
■ Informativ — Transaktion am offenen Markt (bedeutendste)
■ Nicht-informativ (Kauf) — Vergütung, Optionsausübung, Wandlung
■ Nicht-informativ (Verkauf) — Quellensteuer, Verkauf bei Vesting
■ Neutral — Schenkung, Treuhand, Verfall